FDA Greenlights Allergan Drug Vraylar For Schizophrenia And Bipolar Disorder

After enduring 9 weeks of clinical trials, Vraylar was deemed successful enough in treating symptoms of schizophrenia and manic bipolar episodes in adults to earn FDA approval for use.